Logo image of ZENV

ZENVIA INC - A (ZENV) Stock Fundamental Analysis

NASDAQ:ZENV - Nasdaq - KYG9889V1014 - Common Stock - Currency: USD

2.15  -0.1 (-4.44%)

Fundamental Rating

3

ZENV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. ZENV has a bad profitability rating. Also its financial health evaluation is rather negative. ZENV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ZENV has reported negative net income.
In the past year ZENV had a positive cash flow from operations.
In the past 5 years ZENV reported 4 times negative net income.
ZENV had a positive operating cash flow in 4 of the past 5 years.
ZENV Yearly Net Income VS EBIT VS OCF VS FCFZENV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

ZENV's Return On Assets of -2.78% is in line compared to the rest of the industry. ZENV outperforms 53.99% of its industry peers.
Looking at the Return On Equity, with a value of -5.79%, ZENV is in line with its industry, outperforming 54.35% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.10%, ZENV is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
Industry RankSector Rank
ROA -2.78%
ROE -5.79%
ROIC 1.1%
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A
ZENV Yearly ROA, ROE, ROICZENV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 1.70%, ZENV is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
With a Gross Margin value of 38.88%, ZENV is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
ZENV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.7%
PM (TTM) N/A
GM 38.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%
ZENV Yearly Profit, Operating, Gross MarginsZENV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40

2

2. Health

2.1 Basic Checks

ZENV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ZENV has more shares outstanding
The debt/assets ratio for ZENV has been reduced compared to a year ago.
ZENV Yearly Shares OutstandingZENV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
ZENV Yearly Total Debt VS Total AssetsZENV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that ZENV is in the distress zone and has some risk of bankruptcy.
ZENV's Altman-Z score of 0.62 is on the low side compared to the rest of the industry. ZENV is outperformed by 68.48% of its industry peers.
ZENV has a debt to FCF ratio of 9.53. This is a negative value and a sign of low solvency as ZENV would need 9.53 years to pay back of all of its debts.
ZENV's Debt to FCF ratio of 9.53 is in line compared to the rest of the industry. ZENV outperforms 48.55% of its industry peers.
ZENV has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ZENV has a Debt to Equity ratio (0.05) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 9.53
Altman-Z 0.62
ROIC/WACC0.05
WACC21.23%
ZENV Yearly LT Debt VS Equity VS FCFZENV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.50 indicates that ZENV may have some problems paying its short term obligations.
With a Current ratio value of 0.50, ZENV is not doing good in the industry: 93.48% of the companies in the same industry are doing better.
ZENV has a Quick Ratio of 0.50. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.50, ZENV is doing worse than 93.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.5
ZENV Yearly Current Assets VS Current LiabilitesZENV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

6

3. Growth

3.1 Past

ZENV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.33%, which is quite impressive.
The Revenue has grown by 23.50% in the past year. This is a very strong growth!
The Revenue has been growing by 23.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)74.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%463.45%
Revenue 1Y (TTM)23.5%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%30.12%

3.2 Future

The Earnings Per Share is expected to grow by 35.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.84% on average over the next years. This is quite good.
EPS Next Y-17.19%
EPS Next 2Y47.49%
EPS Next 3Y35.77%
EPS Next 5YN/A
Revenue Next Year23.18%
Revenue Next 2Y12.63%
Revenue Next 3Y11.84%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZENV Yearly Revenue VS EstimatesZENV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
ZENV Yearly EPS VS EstimatesZENV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENV. In the last year negative earnings were reported.
ZENV is valuated quite expensively with a Price/Forward Earnings ratio of 77.88.
ZENV's Price/Forward Earnings ratio is in line with the industry average.
ZENV is valuated expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 77.88
ZENV Price Earnings VS Forward Price EarningsZENV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZENV is valued cheaper than 97.46% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZENV is valued a bit cheaper than the industry average as 60.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 50.49
EV/EBITDA 5.33
ZENV Per share dataZENV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ZENV's earnings are expected to grow with 35.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.49%
EPS Next 3Y35.77%

0

5. Dividend

5.1 Amount

No dividends for ZENV!.
Industry RankSector Rank
Dividend Yield N/A

ZENVIA INC - A

NASDAQ:ZENV (2/21/2025, 8:00:02 PM)

2.15

-0.1 (-4.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners7.42%
Inst Owner Change4.59%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap111.52M
Analysts47.5
Price Target1.73 (-19.53%)
Short Float %0.1%
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)161.76%
Min EPS beat(2)-434.31%
Max EPS beat(2)757.84%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.7%
Min Revenue beat(2)1.77%
Max Revenue beat(2)11.63%
Revenue beat(4)4
Avg Revenue beat(4)79.86%
Min Revenue beat(4)0.78%
Max Revenue beat(4)305.25%
Revenue beat(8)6
Avg Revenue beat(8)111.42%
Revenue beat(12)8
Avg Revenue beat(12)70.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.92%
PT rev (3m)-28.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-80%
EPS NY rev (1m)33.64%
EPS NY rev (3m)-34.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 77.88
P/S 0.67
P/FCF 50.49
P/OCF 8.4
P/B 0.72
P/tB N/A
EV/EBITDA 5.33
EPS(TTM)-0.21
EYN/A
EPS(NY)0.03
Fwd EY1.28%
FCF(TTM)0.04
FCFY1.98%
OCF(TTM)0.26
OCFY11.9%
SpS3.19
BVpS2.99
TBVpS-1.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.78%
ROE -5.79%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.21%
ROICexgc N/A
OM 1.7%
PM (TTM) N/A
GM 38.88%
FCFM 1.33%
ROA(3y)-6.48%
ROA(5y)-3.73%
ROE(3y)-12.02%
ROE(5y)-8.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y4.61%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 9.53
Debt/EBITDA 0.44
Cap/Depr 67.29%
Cap/Sales 6.68%
Interest Coverage 0.85
Cash Conversion 68.94%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.5
Altman-Z 0.62
F-Score4
WACC21.23%
ROIC/WACC0.05
Cap/Depr(3y)58.95%
Cap/Depr(5y)58.15%
Cap/Sales(3y)5.54%
Cap/Sales(5y)4.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%463.45%
EPS Next Y-17.19%
EPS Next 2Y47.49%
EPS Next 3Y35.77%
EPS Next 5YN/A
Revenue 1Y (TTM)23.5%
Revenue growth 3Y23.41%
Revenue growth 5Y23.92%
Sales Q2Q%30.12%
Revenue Next Year23.18%
Revenue Next 2Y12.63%
Revenue Next 3Y11.84%
Revenue Next 5YN/A
EBIT growth 1Y119.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2379.67%
EBIT Next 3Y223.69%
EBIT Next 5YN/A
FCF growth 1Y-79.01%
FCF growth 3Y54.83%
FCF growth 5Y27.36%
OCF growth 1Y-24.31%
OCF growth 3Y52.2%
OCF growth 5Y32.63%